Works matching IS 03057453 AND DT 2024 AND VI 79 AND IP 3


Results: 28
    1
    2

    Linezolid brain penetration in neurointensive care patients.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 669, doi. 10.1093/jac/dkae025
    By:
    • Hosmann, Arthur;
    • Moser, Miriam M;
    • Os, Wisse van;
    • Gramms, Leon;
    • Jalali, Valentin al;
    • Codina, Maria Sanz;
    • Plöchl, Walter;
    • Lier, Constantin;
    • Kees, Frieder;
    • Dorn, Christoph;
    • Rössler, Karl;
    • Reinprecht, Andrea;
    • Zeitlinger, Markus
    Publication type:
    Article
    3
    4

    Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomes.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 648, doi. 10.1093/jac/dkae022
    By:
    • Chen, Rou-Zhen;
    • Lu, Po-Liang;
    • Yang, Tsung-Ying;
    • Lin, Shang-Yi;
    • Tang, Hung-Jen;
    • Chang, Feng-Yee;
    • Yang, Ya-Sung;
    • Chiang, Tsung-Ta;
    • Wang, Fu-Der;
    • Wu, Ting-Shu;
    • Shie, Shian-Sen;
    • Ho, Mao-Wang;
    • Liu, Jien-Wei;
    • Shi, Zhi-Yuan;
    • Chou, Chia-Hui;
    • Chuang, Yin-Ching
    Publication type:
    Article
    5
    6
    7
    8

    Riparin II-type benzamides as novel antibiofilm agents against dermatophytes: chemical synthesis, in vitro, ex vivo and in silico evaluation.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 617, doi. 10.1093/jac/dkae013
    By:
    • Rocha, Marcelo Antônio Nóbrega da;
    • Silva, Emanuel Pereira;
    • Silva, Risley Nikael Medeiros;
    • Sousa, Gabriela Ribeiro de;
    • Barbosa-Filho, José Maria;
    • Maia, Mayara dos Santos;
    • Lima, Alberto Shellygton;
    • Souza-Ferrari, Jailton de;
    • Pereira, Fillipe de Oliveira
    Publication type:
    Article
    9
    10

    Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 595, doi. 10.1093/jac/dkae011
    By:
    • Troya, Jesús;
    • Pousada, Guillermo;
    • Micán, Rafael;
    • Galera, Carlos;
    • Sanz, José;
    • de los Santos, Ignacio;
    • Dueñas, Carlos;
    • Cabello, Noemí;
    • Martín, Cristina;
    • Galindo, María Josefa;
    • Garcinuño, María Ángeles;
    • Pedrero-Tomé, Roberto;
    • Buzón, Luis
    Publication type:
    Article
    11
    12

    Use of genotypic HIV DNA testing: a DELPHI-type consensus.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 578, doi. 10.1093/jac/dkae007
    By:
    • Andre-Garnier, Elisabeth;
    • Bocket, Laurence;
    • Bourlet, Thomas;
    • Hocqueloux, Laurent;
    • Lepiller, Quentin;
    • Maillard, Anne;
    • Reigadas, Sandrine;
    • Barriere, Guillaume;
    • Durand, François;
    • Montes, Brigitte;
    • Stefic, Karl;
    • Marcelin, Anne-Geneviève
    Publication type:
    Article
    13
    14
    15

    Determining a urinary-specific antibiogram and risk factors of trimethoprim/sulfamethoxazole, ciprofloxacin and multidrug resistance among Enterobacterales in primary care.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 559, doi. 10.1093/jac/dkae004
    By:
    • Valentine-King, Marissa;
    • Hansen, Michael A;
    • Zoorob, Roger;
    • Schlueter, Matthew;
    • Matas, Jennifer L;
    • Willis, Samuel E;
    • Danek, Lisa C K;
    • Muldrew, Kenneth;
    • Zare, Mohammad;
    • Hudson, Forrest;
    • Atmar, Robert L;
    • Chou, Andrew;
    • Trautner, Barbara W;
    • Grigoryan, Larissa
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28